USC.edu
Are You a Patient?

Jonathan Santoro

Associate Professor of Clinical Pediatrics and Neurology

Image of Jonathan Santoro
Is this your profile? Click to edit
Email [email protected]
Orcid ID CTSI Profile

Education and Training

  • Tulane University, New Orleans, LA — BS — 05/2007 — Neuroscience
  • Tulan University, New Orleans, LA — MS — 05/2008 — Neuroscience
  • Tulane University, New Orleans, LA — MD — 05/2013 — Medicine
  • Stanford University, Palo Alto, CA — 06/2015 — Pediatrics Residency
  • Stanford University, Palo Alto, CA — 06/2018 — Child Neurology Residency
  • Harvard University, Boston, MA — 06/2019 — Neuroimmunology Fellowship

Research Funding

  • Development and Validation of the Down Syndrome Regression Rating Scales
    NIH · R01HD113711 · Sep 20, 2023 – Aug 31, 2028 · Role: Co-Investigator
  • Mechanistic investigation of therapies for Down Syndrome Regression Disorder
    NIH · R61HD109748 · Sep 9, 2022 – Jun 30, 2024 · Role: Co-Investigator
  • Non-invasive biometric screening for cerebrovascular disorders in persons with Down syndrome.
    NIH · K23HL155898 · Feb 17, 2021 – Jan 31, 2026 · Role: Principal Investigator

Research Keywords

  • Down syndrome
  • Moyamoya disease
  • Multiple sclerosis
  • Autoimmune encephalitis
  • Down syndrome regression disorder
  • Neuromyelitis optica spectrum disorders
  • MOG spectrum disorders
  • Pediatric neuroimmunology

Publications

  • Blood pressure and transcranial ultrasound predict moyamoya vasculopathy in Down syndrome. Dev Med Child Neurol. 2026 Sep 29.. View in PubMed
  • The Patient Experience of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Post-Diagnosis: Results from an International Survey. Neurol Ther. 2026 Oct; 15(5):2491-2508.. View in PubMed
  • Pediatric Cerebral Sinus Venous Thrombosis During the First Three Years of the SARS-CoV-2 Pandemic: A Multinational Case Series. Pediatr Blood Cancer. 2026 Oct; 73(10):e70566.. View in PubMed
  • Correction: Serum and cerebral folate are normal in Down Syndrome Regression Disorder. Mol Autism. 2026 Jul 30; 17(1).. View in PubMed
  • Delayed Recognition and Stroke-Predominant Presentation in Down Syndrome-Associated Moyamoya Syndrome. Stroke. 2026 Sep; 57(9):2731-2743.. View in PubMed
  • Patient and Family Perspectives on Point-of-Care Low-Field Brain Magnetic Resonance Imaging for Children in the Emergency Department, Intensive Care Unit, and Hospital Setting. Pediatr Neurol. 2026 Oct; 183:201-206.. View in PubMed
  • Pediatric Neuroinflammatory and Neuropsychiatric Syndromes Associated with Dupilumab Treatment for Atopic Dermatitis. J Pediatr. 2026 Oct; 297:115201.. View in PubMed
  • Electroencephalographic Normalization as a Biomarker of Clinical Recovery in Down Syndrome Regression Disorder. Ann Clin Transl Neurol. 2026 Jun 07.. View in PubMed
  • Promoting Research Excellence in Down Syndrome: Proceedings of the 5th International Conference of the Trisomy 21 Research Society. Neuromolecular Med. 2026 06 06; 28(1).. View in PubMed
  • Immunosuppression in down syndrome regression disorder: a prospective observational cohort study. Brain Commun. 2026; 8(3):fcag203.. View in PubMed

Similar People